Integra Lifesciences Prices $450M Senior Notes at 9.500%

By Philip Seaworth • Monday, October 12 10:54 • Permanent Link

Integra Lifesciences Holdings said it priced $450 million of senior secured notes due 2033 at 9.500%.

The company said the notes are expected to close on or about October 19, 2026. Proceeds, together with borrowings under a new credit facility, will be used to refinance existing credit facilities and cover related fees and expenses.

The new debt adds a long-dated layer to the balance sheet: the notes mature in 2033 and carry a fixed 9.500% coupon. The company described the issuance as part of a broader refinancing transaction. Today the company's shares have moved 0.22% to a price of $13.44. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.